We are live on ! Find out more
CORT icon

Corcept Therapeutics
CORT

207 hedge funds and large institutions have $1.26B invested in Corcept Therapeutics in 2018 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 86 increasing their positions, 64 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

34% more repeat investments, than reductions

Existing positions increased: 86 | Existing positions reduced: 64

1.21% more ownership

Funds ownership: 76.01% → 77.22% (+1.2%)

4% less funds holding

Funds holding: 215 → 207 (-8)

9% less capital invested

Capital invested by funds: $1.38B → $1.26B (-$121M)

21% less first-time investments, than exits

New positions opened: 27 | Existing positions closed: 34

46% less call options, than puts

Call options by funds: $6.35M | Put options by funds: $11.8M

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
207
Holders Change
-8
Holders Change %
-3.72%
% of All Funds
4.73%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
27
Increased
86
Reduced
64
Closed
34
Calls
$6.35M
Puts
$11.8M
Net Calls
-$5.46M
Net Calls Change
+$11.4M

Top Buyers

1
BlackRock
BlackRock
New York
+$21.6M
2
ISL
Ingalls & Snyder LLC
New York
+$15.1M
3
Invesco
Invesco
Georgia
+$13.4M
4
Morgan Stanley
Morgan Stanley
New York
+$9.96M
5
Stifel Financial
Stifel Financial
Missouri
+$6.63M

Top Sellers

1
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$19M
2
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$13.4M
3
JIM
Jupiter Investment Management
United Kingdom
-$7.9M
4
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management
California
-$6.89M
5
NC
Nexthera Capital
New York
-$5.27M
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$221M +$21.6M +1,545,671 +11%
Federated Hermes
2
Federated Hermes
Pennsylvania
$169M +$2.37M +169,712 +1%
Vanguard Group
3
Vanguard Group
Pennsylvania
$145M +$528K +37,781 +0.4%
ISL
4
Ingalls & Snyder LLC
New York
$118M +$15.1M +1,081,270 +15%
CCM
5
Consonance Capital Management
New York
$70.6M +$5.74M +410,457 +9%
Renaissance Technologies
6
Renaissance Technologies
New York
$61.9M +$981K +70,200 +2%
State Street
7
State Street
Massachusetts
$45.2M +$4.45M +318,429 +11%
Invesco
8
Invesco
Georgia
$39M +$13.4M +955,746 +52%
Morgan Stanley
9
Morgan Stanley
New York
$25.7M +$9.96M +712,878 +64%
Dimensional Fund Advisors
10
Dimensional Fund Advisors
Texas
$25M +$1.79M +128,416 +8%
Acadian Asset Management
11
Acadian Asset Management
Massachusetts
$20M -$19M -1,359,742 -49%
Northern Trust
12
Northern Trust
Illinois
$18.4M +$894K +63,994 +5%
Bank of New York Mellon
13
Bank of New York Mellon
New York
$18.2M +$1.42M +101,762 +8%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$15.3M +$1.54M +110,170 +11%
Principal Financial Group
15
Principal Financial Group
Iowa
$12.9M +$1.56M +111,430 +14%
STB
16
S&T Bank
Pennsylvania
$10M +$4.45M +318,254 +80%
Norges Bank
17
Norges Bank
Norway
$9.89M +$1.25M +89,300 +14%
Ameriprise
18
Ameriprise
Minnesota
$8.86M +$946K +67,706 +12%
AAM
19
AMI Asset Management
California
$8.82M -$744K -53,209 -8%
Goldman Sachs
20
Goldman Sachs
New York
$8.05M -$3.7M -264,977 -32%
Charles Schwab
21
Charles Schwab
California
$7.88M +$842K +60,276 +12%
Capital Fund Management (CFM)
22
Capital Fund Management (CFM)
France
$7.58M +$3.21M +229,969 +74%
ORI
23
Oak Ridge Investments
Illinois
$7.34M -$916K -65,570 -11%
AWS
24
AJ Wealth Strategies
New York
$7.21M +$1.02M +73,200 +17%
Stifel Financial
25
Stifel Financial
Missouri
$6.85M +$6.63M +474,155 +3,909%
1
2 3 4 5

CORT Hedge Fund Activity: Q3 2018 in Review

207 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Corcept Therapeutics (CORT) for Q3 2018, worth a combined $1.26B — down 8.8% from $1.38B a quarter earlier.

Sellers outnumbered buyers: 34 funds closed out of CORT and 27 opened new positions — a net loss of 7 holders — while 64 trimmed existing stakes and 86 added.

The largest buyer was BlackRock, adding an estimated $21.6M. The largest seller was Acadian Asset Management, cutting an estimated $19M.

  • 207 institutional investors held Corcept Therapeutics (CORT) as of Q3 2018, down from 215 in Q2 2018.
  • Funds reported $1.26B of Corcept Therapeutics stock for Q3 2018, down 8.8% quarter-over-quarter.
  • 27 funds opened new Corcept Therapeutics positions in Q3 2018 and 34 closed out, a net change of -7 holders.
  • The largest Corcept Therapeutics buyer in Q3 2018 was BlackRock, an estimated $21.6M added.
  • The largest Corcept Therapeutics seller in Q3 2018 was Acadian Asset Management, an estimated $19M sold.

Based on aggregated 13F filings for Q3 2018.